aluates Reports

$ 0.0

Automative

Global FPR1 Antibody Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: November 2025

Report Code: QYRE-Auto-5N17154

Global FPR1 Antibody Market Research Report 2024

BUY CHAPTERS

Global FPR1 Antibody Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-5N17154

Report

November 2025

Pages:169

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abcam

Cell Signaling Technology

Santa Cruz Biotechnology

Novus Biologicals

Thermo Fisher Scientific

R&D Systems

Sigma-aldrich

BioLegend

Origene Technologies

Boster Bio

Proteintech

4a Biotech

R&D Systems

FPR1 Antibody Market Size

The global FPR1 Antibody market is projected to grow from US$ 60.6 million in 2024 to US$ 84.4 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

FPR1 Antibody Market

FPR1 antibody is an immunoglobulin directed against FPR1 (Formyl Peptide Receptor 1, N-formyl peptide receptor 1). FPR1 is a G protein-coupled receptor that can recognize and bind chemical substances such as bacterial-derived N-formyl peptide and plays an important role in immune and inflammatory responses. FPR1 antibodies are usually produced by animal immunization and can be used in scientific research to detect, locate and quantify the expression level of FPR1 protein in cells or tissues. The application of this antibody can help researchers better understand the function of FPR1 in biological processes such as inflammation, immune response, cell migration, and its relationship with the occurrence and development of diseases.

FPR1（Formyl Peptide Receptor 1）作为G蛋白偶联受体，在炎症反应、细胞迁移和癌症发展中发挥着重要作用。因此，FPR1抗体在科研和临床应用中的需求逐渐增长，特别是在肿瘤学和免疫学领域。随着生物技术的不断进步，FPR1抗体的制备技术也在提高。高亲和力、高特异性的抗体能够更好地满足科研和临床的需求，推动FPR1抗体市场的快速发展。总的来说，FPR1抗体市场具有广阔的发展前景和巨大的市场潜力。

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global FPR1 Antibody market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of FPR1 Antibody Market Report

Report Metric	Details
Report Name	FPR1 Antibody Market
Accounted market size in 2024	US$ 60.6 million
Forecasted market size in 2031	US$ 84.4 million
CAGR	4.9%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Monoclonal Antibodies Polyclonal Antibodies
Segment by Application	Immunology Research Biomedical Research Drug Discovery
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abcam, Cell Signaling Technology, Santa Cruz Biotechnology, Novus Biologicals, Thermo Fisher Scientific, R&D Systems, Sigma-Aldrich, BioLegend, OriGene Technologies, Boster Bio, Proteintech, 4a Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the FPR1 Antibody study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is FPR1 Antibody Market growing?

Ans: The FPR1 Antibody Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the FPR1 Antibody Market size in 2031?

Ans: The FPR1 Antibody Market size in 2031 will be US$ 84.4 million.

Who are the main players in the FPR1 Antibody Market report?

Ans: The main players in the FPR1 Antibody Market are Abcam, Cell Signaling Technology, Santa Cruz Biotechnology, Novus Biologicals, Thermo Fisher Scientific, R&D Systems, Sigma-Aldrich, BioLegend, OriGene Technologies, Boster Bio, Proteintech, 4a Biotech

What are the Application segmentation covered in the FPR1 Antibody Market report?

Ans: The Applications covered in the FPR1 Antibody Market report are Immunology Research, Biomedical Research, Drug Discovery

What are the Type segmentation covered in the FPR1 Antibody Market report?

Ans: The Types covered in the FPR1 Antibody Market report are Monoclonal Antibodies, Polyclonal Antibodies

1 Study Coverage

1.1 Introduction to FPR1 Antibody: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global FPR1 Antibody Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibodies

1.2.3 Polyclonal Antibodies

1.3 Market Segmentation by Application

1.3.1 Global FPR1 Antibody Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Immunology Research

1.3.3 Biomedical Research

1.3.4 Drug Discovery

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global FPR1 Antibody Revenue Estimates and Forecasts 2020-2031

2.2 Global FPR1 Antibody Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global FPR1 Antibody Sales Estimates and Forecasts 2020-2031

2.4 Global FPR1 Antibody Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global FPR1 Antibody Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global FPR1 Antibody Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Monoclonal Antibodies Market Size by Manufacturers

3.5.2 Polyclonal Antibodies Market Size by Manufacturers

3.6 Global FPR1 Antibody Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global FPR1 Antibody Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global FPR1 Antibody Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global FPR1 Antibody Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global FPR1 Antibody Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America FPR1 Antibody Sales and Revenue by Type (2020-2031)

6.4 North America FPR1 Antibody Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America FPR1 Antibody Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe FPR1 Antibody Sales and Revenue by Type (2020-2031)

7.4 Europe FPR1 Antibody Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe FPR1 Antibody Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific FPR1 Antibody Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific FPR1 Antibody Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific FPR1 Antibody Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America FPR1 Antibody Sales and Revenue by Type (2020-2031)

9.4 Central and South America FPR1 Antibody Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America FPR1 Antibody Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa FPR1 Antibody Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa FPR1 Antibody Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa FPR1 Antibody Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Abcam

11.1.1 Abcam Corporation Information

11.1.2 Abcam Business Overview

11.1.3 Abcam FPR1 Antibody Product Models, Descriptions and Specifications

11.1.4 Abcam FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Abcam FPR1 Antibody Sales by Product in 2024

11.1.6 Abcam FPR1 Antibody Sales by Application in 2024

11.1.7 Abcam FPR1 Antibody Sales by Geographic Area in 2024

11.1.8 Abcam FPR1 Antibody SWOT Analysis

11.1.9 Abcam Recent Developments

11.2 Cell Signaling Technology

11.2.1 Cell Signaling Technology Corporation Information

11.2.2 Cell Signaling Technology Business Overview

11.2.3 Cell Signaling Technology FPR1 Antibody Product Models, Descriptions and Specifications

11.2.4 Cell Signaling Technology FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Cell Signaling Technology FPR1 Antibody Sales by Product in 2024

11.2.6 Cell Signaling Technology FPR1 Antibody Sales by Application in 2024

11.2.7 Cell Signaling Technology FPR1 Antibody Sales by Geographic Area in 2024

11.2.8 Cell Signaling Technology FPR1 Antibody SWOT Analysis

11.2.9 Cell Signaling Technology Recent Developments

11.3 Santa Cruz Biotechnology

11.3.1 Santa Cruz Biotechnology Corporation Information

11.3.2 Santa Cruz Biotechnology Business Overview

11.3.3 Santa Cruz Biotechnology FPR1 Antibody Product Models, Descriptions and Specifications

11.3.4 Santa Cruz Biotechnology FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Santa Cruz Biotechnology FPR1 Antibody Sales by Product in 2024

11.3.6 Santa Cruz Biotechnology FPR1 Antibody Sales by Application in 2024

11.3.7 Santa Cruz Biotechnology FPR1 Antibody Sales by Geographic Area in 2024

11.3.8 Santa Cruz Biotechnology FPR1 Antibody SWOT Analysis

11.3.9 Santa Cruz Biotechnology Recent Developments

11.4 Novus Biologicals

11.4.1 Novus Biologicals Corporation Information

11.4.2 Novus Biologicals Business Overview

11.4.3 Novus Biologicals FPR1 Antibody Product Models, Descriptions and Specifications

11.4.4 Novus Biologicals FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Novus Biologicals FPR1 Antibody Sales by Product in 2024

11.4.6 Novus Biologicals FPR1 Antibody Sales by Application in 2024

11.4.7 Novus Biologicals FPR1 Antibody Sales by Geographic Area in 2024

11.4.8 Novus Biologicals FPR1 Antibody SWOT Analysis

11.4.9 Novus Biologicals Recent Developments

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Corporation Information

11.5.2 Thermo Fisher Scientific Business Overview

11.5.3 Thermo Fisher Scientific FPR1 Antibody Product Models, Descriptions and Specifications

11.5.4 Thermo Fisher Scientific FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Thermo Fisher Scientific FPR1 Antibody Sales by Product in 2024

11.5.6 Thermo Fisher Scientific FPR1 Antibody Sales by Application in 2024

11.5.7 Thermo Fisher Scientific FPR1 Antibody Sales by Geographic Area in 2024

11.5.8 Thermo Fisher Scientific FPR1 Antibody SWOT Analysis

11.5.9 Thermo Fisher Scientific Recent Developments

11.6 R&D Systems

11.6.1 R&D Systems Corporation Information

11.6.2 R&D Systems Business Overview

11.6.3 R&D Systems FPR1 Antibody Product Models, Descriptions and Specifications

11.6.4 R&D Systems FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 R&D Systems Recent Developments

11.7 Sigma-Aldrich

11.7.1 Sigma-Aldrich Corporation Information

11.7.2 Sigma-Aldrich Business Overview

11.7.3 Sigma-Aldrich FPR1 Antibody Product Models, Descriptions and Specifications

11.7.4 Sigma-Aldrich FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Sigma-Aldrich Recent Developments

11.8 BioLegend

11.8.1 BioLegend Corporation Information

11.8.2 BioLegend Business Overview

11.8.3 BioLegend FPR1 Antibody Product Models, Descriptions and Specifications

11.8.4 BioLegend FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 BioLegend Recent Developments

11.9 OriGene Technologies

11.9.1 OriGene Technologies Corporation Information

11.9.2 OriGene Technologies Business Overview

11.9.3 OriGene Technologies FPR1 Antibody Product Models, Descriptions and Specifications

11.9.4 OriGene Technologies FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 OriGene Technologies Recent Developments

11.10 Boster Bio

11.10.1 Boster Bio Corporation Information

11.10.2 Boster Bio Business Overview

11.10.3 Boster Bio FPR1 Antibody Product Models, Descriptions and Specifications

11.10.4 Boster Bio FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Boster Bio Recent Developments

11.11 Proteintech

11.11.1 Proteintech Corporation Information

11.11.2 Proteintech Business Overview

11.11.3 Proteintech FPR1 Antibody Product Models, Descriptions and Specifications

11.11.4 Proteintech FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Proteintech Recent Developments

11.12 4a Biotech

11.12.1 4a Biotech Corporation Information

11.12.2 4a Biotech Business Overview

11.12.3 4a Biotech FPR1 Antibody Product Models, Descriptions and Specifications

11.12.4 4a Biotech FPR1 Antibody Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 4a Biotech Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 FPR1 Antibody Industry Chain

12.2 FPR1 Antibody Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 FPR1 Antibody Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 FPR1 Antibody Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 FPR1 Antibody Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global FPR1 Antibody Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Abcam

Cell Signaling Technology

Santa Cruz Biotechnology

Novus Biologicals

Thermo Fisher Scientific

R&D Systems

Sigma-aldrich

BioLegend

Origene Technologies

Boster Bio

Proteintech

4a Biotech

R&D Systems

List of Tables

Table 1. Global FPR1 Antibody Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global FPR1 Antibody Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global FPR1 Antibody Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global FPR1 Antibody Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global FPR1 Antibody Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global FPR1 Antibody Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global FPR1 Antibody Sales by Region (2020-2025) & (K Units)

Table 8. Global FPR1 Antibody Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global FPR1 Antibody Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global FPR1 Antibody Sales Share by Manufacturers (2020-2025)

Table 12. Global FPR1 Antibody Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global FPR1 Antibody Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global FPR1 Antibody by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FPR1 Antibody as of 2024)

Table 16. Global FPR1 Antibody Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global FPR1 Antibody Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers FPR1 Antibody Manufacturing Base and Headquarters

Table 19. Global FPR1 Antibody Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global FPR1 Antibody Sales by Type (2020-2025) & (K Units)

Table 23. Global FPR1 Antibody Sales by Type (2026-2031) & (K Units)

Table 24. Global FPR1 Antibody Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global FPR1 Antibody Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global FPR1 Antibody ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global FPR1 Antibody Sales by Application (2020-2025) & (K Units)

Table 29. Global FPR1 Antibody Sales by Application (2026-2031) & (K Units)

Table 30. FPR1 Antibody High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global FPR1 Antibody Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global FPR1 Antibody Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global FPR1 Antibody ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America FPR1 Antibody Growth Accelerators and Market Barriers

Table 37. North America FPR1 Antibody Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America FPR1 Antibody Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe FPR1 Antibody Growth Accelerators and Market Barriers

Table 40. Europe FPR1 Antibody Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe FPR1 Antibody Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific FPR1 Antibody Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific FPR1 Antibody Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific FPR1 Antibody Growth Accelerators and Market Barriers

Table 45. Southeast Asia FPR1 Antibody Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America FPR1 Antibody Investment Opportunities and Key Challenges

Table 47. Central and South America FPR1 Antibody Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa FPR1 Antibody Investment Opportunities and Key Challenges

Table 49. Middle East and Africa FPR1 Antibody Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Abcam Corporation Information

Table 51. Abcam Description and Major Businesses

Table 52. Abcam Product Models, Descriptions and Specifications

Table 53. Abcam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Abcam Sales Value Proportion by Product in 2024

Table 55. Abcam Sales Value Proportion by Application in 2024

Table 56. Abcam Sales Value Proportion by Geographic Area in 2024

Table 57. Abcam FPR1 Antibody SWOT Analysis

Table 58. Abcam Recent Developments

Table 59. Cell Signaling Technology Corporation Information

Table 60. Cell Signaling Technology Description and Major Businesses

Table 61. Cell Signaling Technology Product Models, Descriptions and Specifications

Table 62. Cell Signaling Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Cell Signaling Technology Sales Value Proportion by Product in 2024

Table 64. Cell Signaling Technology Sales Value Proportion by Application in 2024

Table 65. Cell Signaling Technology Sales Value Proportion by Geographic Area in 2024

Table 66. Cell Signaling Technology FPR1 Antibody SWOT Analysis

Table 67. Cell Signaling Technology Recent Developments

Table 68. Santa Cruz Biotechnology Corporation Information

Table 69. Santa Cruz Biotechnology Description and Major Businesses

Table 70. Santa Cruz Biotechnology Product Models, Descriptions and Specifications

Table 71. Santa Cruz Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Santa Cruz Biotechnology Sales Value Proportion by Product in 2024

Table 73. Santa Cruz Biotechnology Sales Value Proportion by Application in 2024

Table 74. Santa Cruz Biotechnology Sales Value Proportion by Geographic Area in 2024

Table 75. Santa Cruz Biotechnology FPR1 Antibody SWOT Analysis

Table 76. Santa Cruz Biotechnology Recent Developments

Table 77. Novus Biologicals Corporation Information

Table 78. Novus Biologicals Description and Major Businesses

Table 79. Novus Biologicals Product Models, Descriptions and Specifications

Table 80. Novus Biologicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Novus Biologicals Sales Value Proportion by Product in 2024

Table 82. Novus Biologicals Sales Value Proportion by Application in 2024

Table 83. Novus Biologicals Sales Value Proportion by Geographic Area in 2024

Table 84. Novus Biologicals FPR1 Antibody SWOT Analysis

Table 85. Novus Biologicals Recent Developments

Table 86. Thermo Fisher Scientific Corporation Information

Table 87. Thermo Fisher Scientific Description and Major Businesses

Table 88. Thermo Fisher Scientific Product Models, Descriptions and Specifications

Table 89. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Thermo Fisher Scientific Sales Value Proportion by Product in 2024

Table 91. Thermo Fisher Scientific Sales Value Proportion by Application in 2024

Table 92. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024

Table 93. Thermo Fisher Scientific FPR1 Antibody SWOT Analysis

Table 94. Thermo Fisher Scientific Recent Developments

Table 95. R&D Systems Corporation Information

Table 96. R&D Systems Description and Major Businesses

Table 97. R&D Systems Product Models, Descriptions and Specifications

Table 98. R&D Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. R&D Systems Recent Developments

Table 100. Sigma-Aldrich Corporation Information

Table 101. Sigma-Aldrich Description and Major Businesses

Table 102. Sigma-Aldrich Product Models, Descriptions and Specifications

Table 103. Sigma-Aldrich Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Sigma-Aldrich Recent Developments

Table 105. BioLegend Corporation Information

Table 106. BioLegend Description and Major Businesses

Table 107. BioLegend Product Models, Descriptions and Specifications

Table 108. BioLegend Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. BioLegend Recent Developments

Table 110. OriGene Technologies Corporation Information

Table 111. OriGene Technologies Description and Major Businesses

Table 112. OriGene Technologies Product Models, Descriptions and Specifications

Table 113. OriGene Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. OriGene Technologies Recent Developments

Table 115. Boster Bio Corporation Information

Table 116. Boster Bio Description and Major Businesses

Table 117. Boster Bio Product Models, Descriptions and Specifications

Table 118. Boster Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Boster Bio Recent Developments

Table 120. Proteintech Corporation Information

Table 121. Proteintech Description and Major Businesses

Table 122. Proteintech Product Models, Descriptions and Specifications

Table 123. Proteintech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Proteintech Recent Developments

Table 125. 4a Biotech Corporation Information

Table 126. 4a Biotech Description and Major Businesses

Table 127. 4a Biotech Product Models, Descriptions and Specifications

Table 128. 4a Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. 4a Biotech Recent Developments

Table 130. Key Raw Materials Distribution

Table 131. Raw Materials Key Suppliers

Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 133. Milestones in Production Technology Evolution

Table 134. Distributors List

Table 135. Market Trends and Market Evolution

Table 136. Market Drivers and Opportunities

Table 137. Market Challenges, Risks, and Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. FPR1 Antibody Product Picture

Figure 2. Global FPR1 Antibody Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Monoclonal Antibodies Product Picture

Figure 4. Polyclonal Antibodies Product Picture

Figure 5. Global FPR1 Antibody Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Immunology Research

Figure 7. Biomedical Research

Figure 8. Drug Discovery

Figure 9. FPR1 Antibody Report Years Considered

Figure 10. Global FPR1 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 12. Global FPR1 Antibody Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global FPR1 Antibody Revenue Market Share by Region (2020-2031)

Figure 14. Global FPR1 Antibody Sales (2020-2031) & (K Units)

Figure 15. Global FPR1 Antibody Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global FPR1 Antibody Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers FPR1 Antibody Sales Volume Market Share in 2024

Figure 18. Global FPR1 Antibody Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Monoclonal Antibodies Revenue Market Share by Manufacturer in 2024

Figure 21. Polyclonal Antibodies Revenue Market Share by Manufacturer in 2024

Figure 22. Global FPR1 Antibody Sales Market Share by Type (2020-2031)

Figure 23. Global FPR1 Antibody Revenue Market Share by Type (2020-2031)

Figure 24. Global FPR1 Antibody Sales Market Share by Application (2020-2031)

Figure 25. Global FPR1 Antibody Revenue Market Share by Application (2020-2031)

Figure 26. North America FPR1 Antibody Sales YoY (2020-2031) & (K Units)

Figure 27. North America FPR1 Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers FPR1 Antibody Sales Revenue (US$ Million) in 2024

Figure 29. North America FPR1 Antibody Sales Volume (K Units) by Type (2020- 2031)

Figure 30. North America FPR1 Antibody Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America FPR1 Antibody Sales Volume (K Units) by Application (2020-2031)

Figure 32. North America FPR1 Antibody Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 34. Canada FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 36. Europe FPR1 Antibody Sales YoY (2020-2031) & (K Units)

Figure 37. Europe FPR1 Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers FPR1 Antibody Sales Revenue (US$ Million) in 2024

Figure 39. Europe FPR1 Antibody Sales Volume (K Units) by Type (2020-2031)

Figure 40. Europe FPR1 Antibody Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe FPR1 Antibody Sales Volume (K Units) by Application (2020-2031)

Figure 42. Europe FPR1 Antibody Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 44. France FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 46. Italy FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 47. Russia FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific FPR1 Antibody Sales YoY (2020-2031) & (K Units)

Figure 49. Asia-Pacific FPR1 Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers FPR1 Antibody Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific FPR1 Antibody Sales Volume (K Units) by Type (2020- 2031)

Figure 52. Asia-Pacific FPR1 Antibody Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific FPR1 Antibody Sales Volume (K Units) by Application (2020-2031)

Figure 54. Asia-Pacific FPR1 Antibody Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 56. Japan FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 59. India FPR1 Antibody Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America FPR1 Antibody Sales YoY (2020-2031) & (K Units)

Figure 61. Central and South America FPR1 Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers FPR1 Antibody Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America FPR1 Antibody Sales Volume (K Units) by Type (2021-2031)

Figure 64. Central and South America FPR1 Antibody Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America FPR1 Antibody Sales Volume (K Units) by Application (2020-2031)

Figure 66. Central and South America FPR1 Antibody Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil FPR1 Antibody Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina FPR1 Antibody Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa FPR1 Antibody Sales YoY (2020-2031) & (K Units)

Figure 70. Middle East and Africa FPR1 Antibody Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers FPR1 Antibody Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa FPR1 Antibody Sales Volume (K Units) by Type (2021-2031)

Figure 73. South America FPR1 Antibody Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa FPR1 Antibody Sales Volume (K Units) by Application (2020-2031)

Figure 75. Middle East and Africa FPR1 Antibody Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries FPR1 Antibody Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey FPR1 Antibody Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt FPR1 Antibody Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa FPR1 Antibody Revenue (2020-2025) & (US$ Million)

Figure 80. FPR1 Antibody Industry Chain Mapping

Figure 81. Regional FPR1 Antibody Manufacturing Base Distribution (%)

Figure 82. Global FPR1 Antibody Production Market Share by Region (2020-2031)

Figure 83. FPR1 Antibody Production Process

Figure 84. Regional FPR1 Antibody Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global FPR1 Activator Market Research Report 2024

Global F11R Antibody Market Research Report 2024

Global SFRP1 ELISA Kits Market Research Report 2024

Global FOLR1 ELISA Kits Market Research Report 2024

Global FGFR5 Antibody Market Research Report 2024

Global MUC1 Antibody Market Research Report 2024

Global IGF1R Antibody Market Research Report 2024

FABP1 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Toll like Receptor Antibodies Market Research Report 2024

Global Research Grade Antibodies Market Research Report 2024

Global Interferon Gamma Receptor 1 IFN γ R1 ELISA Kit Market Research Report 2024

Global Immunoglobulin G Antibody Therapeutics Market Insights Forecast to 2030

Global Mitogen Activated Protein Kinase Kinase 1 MEK1 Antibody Market Research Report 2024

Global Combination Antibody Therapy Market Research Report 2024

Global GFP Antibody Market Research Report 2024

Global Synaptotagmin 1 Antibody Market Research Report 2024

Global Fibroblast Growth Factor Receptor 3 FGFR3 Antibody Market Research Report 2024

Global UBAP1 Antibody Market Research Report 2024

Global BAG1 Antibody Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions